Literature DB >> 19342158

Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis.

Wen-ting Xu1, Zhen-yu Bian, Qi-ming Fan, Gang Li, Ting-ting Tang.   

Abstract

In an effort to study the interaction between MSCs and osteosarcoma, we established an animal model of primary osteosarcoma in nude mice using Saos-2 cells. hMSCs, labeled with adv-GFP, were injected through the caudal vein. We observed that exogenous hMSCs targeted the osteosarcoma site and promoted its growth and pulmonary metastasis in vivo. To elucidate the underlying mechanisms, we employed transwell, neutralization antibody and MTT assays in vitro. hMSCs migrated toward the conditioned medium from Saos-2 cells, and SDF-1 was involved in this migration. Likewise, Saos-2 cells migrated toward the conditioned medium from hMSCs and CCL5 played an important role in this migration. Furthermore, proliferation of Saos-2 cells was enhanced by the conditioned medium from hMSCs and CCL5 was at least partly responsible for this enhancement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342158     DOI: 10.1016/j.canlet.2009.02.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  75 in total

Review 1.  Modeling sarcomagenesis using multipotent mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Pablo Menendez
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

Review 2.  The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.

Authors:  Jilong Yang; Zhiwu Ren; Xiaoling Du; Mengze Hao; Wenya Zhou
Journal:  Stem Cell Investig       Date:  2014-10-27

Review 3.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

5.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

6.  Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells.

Authors:  Scott A Bergfeld; Laurence Blavier; Yves A DeClerck
Journal:  Mol Cancer Ther       Date:  2014-02-06       Impact factor: 6.261

Review 7.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

8.  Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues.

Authors:  Jiabo Hu; Zhongwei Zhou; Shunbin Shi; Xiaozhong Zhu; Xiaohui Wang; Wei Zhang; Sanqiang Hu; Hui Qian; Wenrong Xu
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

9.  Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

Authors:  Pierre Perrot; Julie Rousseau; Anne-Laure Bouffaut; Françoise Rédini; Elisabeth Cassagnau; Frédéric Deschaseaux; Marie-Françoise Heymann; Dominique Heymann; Franck Duteille; Valérie Trichet; François Gouin
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

10.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.